SPARING ORGANS AT RISK WITH SIMULTANEOUS INTEGRATED BOOST VOLUMETRIC MODULATED ARC THERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER: AN AUTOMATIC TREATMENT PLANNING STUDY

Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study

Daquan Wang,1,* Jiayun Chen,1,* Xiaodong Zhang,2 Tao Zhang,1 Luhua Wang,1 Qinfu Feng,1 Zongmei Zhou,1 Jianrong Dai,1 Nan Bi1 1Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of

read more

Insights into the CD1 lipidome

CD1 isoforms are MHC class I-like molecules that present lipid-antigens read more to T cells and have been associated with a variety of immune responses.The lipid repertoire bound and presented by the four CD1 isoforms may be influenced by factors such as the cellular lipidome, subcellular microenvironment, and the properties of the binding pocket.

read more